Insulet Corp. (PODD)

81.89
NASDAQ : Health Technology
Prev Close 81.73
Day Low/High 80.22 / 83.93
52 Wk Low/High 67.43 / 108.91
Avg Volume 603.20K
Exchange NASDAQ
Shares Outstanding 59.08M
Market Cap 4.83B
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Omnipod® Insulin Management System Now Available For Use In Europe With Fiasp® Fast-Acting Insulin

Omnipod® Insulin Management System Now Available For Use In Europe With Fiasp® Fast-Acting Insulin

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Novo Nordisk's Fiasp ® (Fast-Acting Insulin Aspart) has...

Insulet To Announce Third Quarter 2018 Financial Results On November 1, 2018

Insulet To Announce Third Quarter 2018 Financial Results On November 1, 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2018...

Insulet Announces Shacey Petrovic, President And COO, Promoted To CEO, Effective January 1, 2019; Patrick Sullivan Will Retire As Chairman And CEO At The End Of 2018

Insulet Announces Shacey Petrovic, President And COO, Promoted To CEO, Effective January 1, 2019; Patrick Sullivan Will Retire As Chairman And CEO At The End Of 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that Shacey Petrovic, President and Chief Operating Officer,...

Insulet To Present At Upcoming Investor Conferences

Insulet To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences in New York City, New York:...

Insulet To Showcase Its Omnipod DASH™ Insulin Management System At The American Association Of Diabetes Educators Annual Conference

Insulet To Showcase Its Omnipod DASH™ Insulin Management System At The American Association Of Diabetes Educators Annual Conference

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it will showcase its recently FDA cleared Omnipod DASH™...

Insulet Extends Partnership With Glooko In Europe To Optimise Diabetes Data Management

Insulet Extends Partnership With Glooko In Europe To Optimise Diabetes Data Management

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has partnered with Glooko ®, Inc.

Insulet To Announce Second Quarter 2018 Financial Results On August 2, 2018

Insulet To Announce Second Quarter 2018 Financial Results On August 2, 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2018...

Insulet Partners With The International Diabetes Federation Europe To Support Advocacy Activities Across The Continent

Insulet Partners With The International Diabetes Federation Europe To Support Advocacy Activities Across The Continent

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in  tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today announced it has entered into a partnership with the European Region...

Insulet's Omnipod Insulin Management System; Waterproof*, Tubeless Pod, And Handheld Wireless Personal Diabetes Manager With Built In BGM (Photo: Business Wire)

Insulet's Omnipod Insulin Management System; Waterproof*, Tubeless Pod, And Handheld Wireless Personal Diabetes Manager With Built In BGM (Photo: Business Wire)

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the Omnipod System has been selected as the preferred insulin pump...

Insulet Assumes Direct Operations Of Its Omnipod® Insulin Management System Product Line In Europe

Insulet Assumes Direct Operations Of Its Omnipod® Insulin Management System Product Line In Europe

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced as of July 1, it has assumed direct commercial operations in Europe...

Insulet Presents Positive Clinical Trial Results For The Omnipod® Horizon™ Hybrid Closed-Loop System At The American Diabetes Association's 78th Scientific Sessions

Insulet Presents Positive Clinical Trial Results For The Omnipod® Horizon™ Hybrid Closed-Loop System At The American Diabetes Association's 78th Scientific Sessions

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that positive results from the most recent clinical trial of the...

Insulet To Unveil New Omnipod® DASHTM System And Present Innovative Research At The American Diabetes Association's 78th Scientific Sessions

Insulet To Unveil New Omnipod® DASHTM System And Present Innovative Research At The American Diabetes Association's 78th Scientific Sessions

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it will showcase its recently FDA cleared Omnipod DASH TM Insulin...

Insulet's Omnipod® DASH™ Insulin Management System Receives FDA 510(k) Clearance

Insulet's Omnipod® DASH™ Insulin Management System Receives FDA 510(k) Clearance

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced FDA 510(k) clearance of the Omnipod DASH TM Insulin Management...

Insulet Achieves Key Milestones To Support Its Transition To Direct Operations In Europe On July 1, 2018

Insulet Achieves Key Milestones To Support Its Transition To Direct Operations In Europe On July 1, 2018

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has achieved key milestones as it transitions to direct...

The Week Ahead: Key Earnings, Data and, Oh, a Fed Rate Decision. Welcome to May

The Week Ahead: Key Earnings, Data and, Oh, a Fed Rate Decision. Welcome to May

If you thought last week was busy, hang onto your hats.

Insulet To Announce First Quarter 2018 Financial Results On May 3, 2018

Insulet To Announce First Quarter 2018 Financial Results On May 3, 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Insulet To Share Omnipod Clinical Data At Three Major European National Diabetes Congresses

Insulet To Share Omnipod Clinical Data At Three Major European National Diabetes Congresses

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), announced that it will have a strong...

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ:PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor...

Insulet Reports Fourth Quarter Revenue Of $130.5 Million, Up 26%, And Gross Margin Up 210 Basis Points, Exceeding Expectations

Insulet Reports Fourth Quarter Revenue Of $130.5 Million, Up 26%, And Gross Margin Up 210 Basis Points, Exceeding Expectations

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced promising new data for...

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/12/2018 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 5.63 "days to cover" versus the median component at 4.53. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that the...

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 36th Annual J.

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 29th Annual Piper Jaffray...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the Jefferies 2017 London...

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/31/2017 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 10.90 "days to cover" versus the median component at 5.18. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

TheStreet Quant Rating: C- (Hold)